| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 1.28e-04 | 739 | 53 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 3.98e-04 | 54 | 53 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 5.19e-04 | 140 | 53 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 5.29e-04 | 13 | 53 | 2 | GO:0097677 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 6.39e-05 | 269 | 53 | 6 | GO:0002064 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 9.63e-05 | 421 | 53 | 7 | GO:0048638 | |
| GeneOntologyBiologicalProcess | respiratory system development | 1.27e-04 | 305 | 53 | 6 | GO:0060541 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 1.35e-04 | 7 | 53 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 1.80e-04 | 8 | 53 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.85e-04 | 802 | 53 | 9 | GO:0048812 | |
| GeneOntologyBiologicalProcess | axis specification | 2.03e-04 | 113 | 53 | 4 | GO:0009798 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 2.12e-04 | 640 | 53 | 8 | GO:1903131 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.16e-04 | 819 | 53 | 9 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.31e-04 | 826 | 53 | 9 | GO:0048858 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.72e-04 | 351 | 53 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | cell fate determination | 2.88e-04 | 50 | 53 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 3.38e-04 | 870 | 53 | 9 | GO:0030855 | |
| GeneOntologyBiologicalProcess | semicircular canal development | 3.51e-04 | 11 | 53 | 2 | GO:0060872 | |
| GeneOntologyBiologicalProcess | pattern specification process | 3.76e-04 | 526 | 53 | 7 | GO:0007389 | |
| HumanPheno | Duplication of phalanx of hallux | 5.79e-05 | 14 | 29 | 3 | HP:0010066 | |
| HumanPheno | Duplication of phalanx of toe | 7.21e-05 | 15 | 29 | 3 | HP:0010181 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 9.36e-05 | 3 | 29 | 2 | HP:0005895 | |
| HumanPheno | Abdominal situs inversus | 1.18e-04 | 142 | 29 | 6 | HP:0003363 | |
| HumanPheno | Situs inversus totalis | 1.18e-04 | 142 | 29 | 6 | HP:0001696 | |
| HumanPheno | Abnormal spatial orientation of the cardiac segments | 1.18e-04 | 142 | 29 | 6 | HP:0011534 | |
| HumanPheno | Abnormality of abdominal situs | 1.18e-04 | 142 | 29 | 6 | HP:0011620 | |
| HumanPheno | Heterotaxy | 1.33e-04 | 145 | 29 | 6 | HP:0030853 | |
| HumanPheno | Compulsive behaviors | 2.13e-04 | 158 | 29 | 6 | HP:0000722 | |
| HumanPheno | Dislocated radial head | 2.20e-04 | 54 | 29 | 4 | HP:0003083 | |
| HumanPheno | Dextrocardia | 2.20e-04 | 159 | 29 | 6 | HP:0001651 | |
| HumanPheno | Abnormal anatomic location of the heart | 2.28e-04 | 160 | 29 | 6 | HP:0004307 | |
| HumanPheno | Abnormality of the radial head | 2.72e-04 | 57 | 29 | 4 | HP:0003995 | |
| MousePheno | abnormal embryonic growth/weight/body size | ALX3 ELOA OTX2 PIEZO2 FLYWCH1 PEG10 PKD1L1 GATA2 BICRAL CPD CHD7 TCF7L1 EP300 NOTCH2 KIAA0753 ZNF503 | 1.82e-06 | 1295 | 46 | 16 | MP:0002088 |
| MousePheno | embryonic growth retardation | ALX3 ELOA OTX2 PEG10 PKD1L1 GATA2 BICRAL CHD7 EP300 NOTCH2 KIAA0753 ZNF503 | 4.47e-06 | 763 | 46 | 12 | MP:0003984 |
| MousePheno | abnormal prenatal growth/weight/body size | ALX3 ELOA OTX2 PIEZO2 FLYWCH1 PEG10 PKD1L1 GATA2 BICRAL CPD CHD7 TCF7L1 EP300 NOTCH2 KIAA0753 ZNF503 | 1.16e-05 | 1493 | 46 | 16 | MP:0004196 |
| MousePheno | prenatal growth retardation | ALX3 ELOA OTX2 PEG10 PKD1L1 GATA2 BICRAL CHD7 EP300 NOTCH2 KIAA0753 ZNF503 | 1.68e-05 | 869 | 46 | 12 | MP:0010865 |
| MousePheno | decreased embryonic neuroepithelium thickness | 3.66e-05 | 20 | 46 | 3 | MP:0012703 | |
| MousePheno | edema | 9.66e-05 | 581 | 46 | 9 | MP:0001785 | |
| MousePheno | abnormal embryo turning | 1.62e-04 | 251 | 46 | 6 | MP:0001700 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | ALX3 OTX2 CEBPA NTRK1 PKD1L1 GATA2 FOXP1 CHD7 TCF7L1 EP300 NOTCH2 BAHCC1 | 2.05e-04 | 1124 | 46 | 12 | MP:0011112 |
| MousePheno | perinatal lethality | ALX3 ARID1B OTX2 CEBPA GATA2 SCNN1A TCF7L1 EP300 NOTCH2 KIF7 ZNF503 BAHCC1 | 2.16e-04 | 1130 | 46 | 12 | MP:0002081 |
| Domain | TLV_coat | 1.71e-04 | 7 | 54 | 2 | PF00429 | |
| Domain | TLV/ENV_coat_polyprotein | 2.27e-04 | 8 | 54 | 2 | IPR018154 | |
| Domain | Kinesin_motor_CS | 6.26e-03 | 41 | 54 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 6.87e-03 | 43 | 54 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 7.18e-03 | 44 | 54 | 2 | PS00411 | |
| Domain | - | 7.18e-03 | 44 | 54 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 7.18e-03 | 44 | 54 | 2 | IPR001752 | |
| Domain | Kinesin | 7.18e-03 | 44 | 54 | 2 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 7.18e-03 | 44 | 54 | 2 | PS50067 | |
| Domain | KISc | 7.18e-03 | 44 | 54 | 2 | SM00129 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 8.49e-05 | 32 | 38 | 3 | M39333 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 9.32e-05 | 33 | 38 | 3 | MM15869 | |
| Pathway | WP_CANCER_PATHWAYS | 3.57e-04 | 507 | 38 | 7 | M48302 | |
| Pathway | PID_AR_TF_PATHWAY | 3.86e-04 | 53 | 38 | 3 | M151 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.59e-04 | 12 | 38 | 2 | M27159 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 5.24e-04 | 250 | 38 | 5 | M27554 | |
| Pathway | WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS | 5.42e-04 | 13 | 38 | 2 | M39753 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 5.73e-04 | 143 | 38 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 6.31e-04 | 14 | 38 | 2 | M47414 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.03e-04 | 68 | 38 | 3 | M27303 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 8.03e-04 | 68 | 38 | 3 | M48322 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 8.29e-04 | 16 | 38 | 2 | M39675 | |
| Pubmed | Parcellation of the striatal complex into dorsal and ventral districts. | 6.93e-07 | 42 | 57 | 4 | 32170006 | |
| Pubmed | ARID1B FOXP1 BICRAL OSMR SIPA1L2 TCF7L1 EP300 NOTCH2 ZNF687 KIF7 BAHCC1 | 1.69e-06 | 1116 | 57 | 11 | 31753913 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.72e-06 | 351 | 57 | 7 | 38297188 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27389056 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 1563207 | ||
| Pubmed | Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. | 2.64e-06 | 2 | 57 | 2 | 22086955 | |
| Pubmed | p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. | 2.64e-06 | 2 | 57 | 2 | 11340085 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 18826608 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 25404732 | ||
| Pubmed | Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML. | 2.64e-06 | 2 | 57 | 2 | 33831168 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 22649106 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27375010 | ||
| Pubmed | Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia. | 2.64e-06 | 2 | 57 | 2 | 24033149 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 23555306 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 32330454 | ||
| Pubmed | Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations. | 2.64e-06 | 2 | 57 | 2 | 25611491 | |
| Pubmed | 2.79e-06 | 17 | 57 | 3 | 18330926 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.94e-06 | 398 | 57 | 7 | 35016035 | |
| Pubmed | 6.29e-06 | 22 | 57 | 3 | 21775418 | ||
| Pubmed | Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA). | 7.91e-06 | 3 | 57 | 2 | 32430494 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 23521373 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 27443289 | ||
| Pubmed | Molecular characterization of the intact mouse muscle spindle using a multi-omics approach. | 7.91e-06 | 3 | 57 | 2 | 36744866 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15001660 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25855601 | ||
| Pubmed | Directed differentiation of telencephalic precursors from embryonic stem cells. | 9.36e-06 | 25 | 57 | 3 | 15696161 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 21356387 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 11278891 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 15632071 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 24216764 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 32738303 | ||
| Pubmed | 1.64e-05 | 30 | 57 | 3 | 25804738 | ||
| Pubmed | ARID1B ATXN2 PEG10 SVIL GATA2 FOXP1 CHD7 EP300 ZNF687 KIF7 ZNF503 | 1.76e-05 | 1429 | 57 | 11 | 35140242 | |
| Pubmed | 2.41e-05 | 34 | 57 | 3 | 12086465 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 27681176 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 12861022 | ||
| Pubmed | 2.87e-05 | 36 | 57 | 3 | 22278924 | ||
| Pubmed | 3.66e-05 | 39 | 57 | 3 | 25859222 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 38816354 | ||
| Pubmed | Coordinated hedgehog signaling induces new hair follicles in adult skin. | 3.94e-05 | 6 | 57 | 2 | 32178760 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 19020777 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 8896557 | ||
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 23085571 | ||
| Pubmed | Individual retinal progenitor cells display extensive heterogeneity of gene expression. | 4.26e-05 | 41 | 57 | 3 | 18270576 | |
| Pubmed | 4.66e-05 | 396 | 57 | 6 | 26687479 | ||
| Pubmed | 5.27e-05 | 44 | 57 | 3 | 19322198 | ||
| Pubmed | The Wnt/beta-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis. | 5.51e-05 | 7 | 57 | 2 | 16936075 | |
| Pubmed | Essential function of oncostatin m in nociceptive neurons of dorsal root ganglia. | 5.51e-05 | 7 | 57 | 2 | 14985435 | |
| Pubmed | 5.51e-05 | 7 | 57 | 2 | 24368733 | ||
| Pubmed | 6.31e-05 | 130 | 57 | 4 | 19386638 | ||
| Pubmed | 6.31e-05 | 130 | 57 | 4 | 12421765 | ||
| Pubmed | 7.10e-05 | 134 | 57 | 4 | 19030180 | ||
| Pubmed | 7.19e-05 | 1103 | 57 | 9 | 34189442 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 7.29e-05 | 1105 | 57 | 9 | 35748872 | |
| Pubmed | A ciliopathy complex builds distal appendages to initiate ciliogenesis. | 7.34e-05 | 8 | 57 | 2 | 34241634 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 33504453 | ||
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 38408234 | ||
| Pubmed | 8.08e-05 | 638 | 57 | 7 | 31182584 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 8.77e-05 | 877 | 57 | 8 | 20211142 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 21795282 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 17395647 | ||
| Pubmed | Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. | 9.43e-05 | 9 | 57 | 2 | 21596839 | |
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 1.03e-04 | 55 | 57 | 3 | 32561725 | |
| Pubmed | 1.15e-04 | 57 | 57 | 3 | 35377797 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 19549984 | ||
| Pubmed | Tectal-derived interneurons contribute to phasic and tonic inhibition in the visual thalamus. | 1.18e-04 | 10 | 57 | 2 | 27929058 | |
| Pubmed | GCN5 and p300 share essential functions during early embryogenesis. | 1.18e-04 | 10 | 57 | 2 | 15937931 | |
| Pubmed | 1.19e-04 | 153 | 57 | 4 | 10718198 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 20478998 | ||
| Pubmed | mTORC1 activity is essential for erythropoiesis and B cell lineage commitment. | 1.44e-04 | 11 | 57 | 2 | 31729420 | |
| Pubmed | Duration of Shh signaling contributes to mDA neuron diversity. | 1.44e-04 | 11 | 57 | 2 | 23201023 | |
| Pubmed | Zfp503/Nlz2 Is Required for RPE Differentiation and Optic Fissure Closure. | 1.44e-04 | 11 | 57 | 2 | 36326727 | |
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 28165338 | ||
| Pubmed | The onecut transcription factor hepatocyte nuclear factor-6 controls B lymphopoiesis in fetal liver. | 1.72e-04 | 12 | 57 | 2 | 12874218 | |
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 20736290 | ||
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 20150232 | ||
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 23684982 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 25127144 | ||
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 19592253 | ||
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 25581370 | ||
| Pubmed | Niche-mediated repair of airways is directed in an occupant-dependent manner. | 2.37e-04 | 14 | 57 | 2 | 36543133 | |
| Pubmed | 2.37e-04 | 14 | 57 | 2 | 33195246 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.43e-04 | 536 | 57 | 6 | 15840001 | |
| Pubmed | 2.48e-04 | 538 | 57 | 6 | 10512203 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 26439735 | ||
| Pubmed | Arx Expression Suppresses Ventralization of the Developing Dorsal Forebrain. | 2.73e-04 | 15 | 57 | 2 | 30659230 | |
| Pubmed | Mapping lineage progression of somatic progenitor cells in the mouse fetal testis. | 2.73e-04 | 15 | 57 | 2 | 27621062 | |
| Pubmed | Jarid2 promotes temporal progression of retinal progenitors via repression of Foxp1. | 2.73e-04 | 15 | 57 | 2 | 36924502 | |
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 18930042 | ||
| Pubmed | Tcf7l1 prepares epiblast cells in the gastrulating mouse embryo for lineage specification. | 2.73e-04 | 15 | 57 | 2 | 23487311 | |
| Pubmed | 2.77e-04 | 191 | 57 | 4 | 24146773 | ||
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 23034632 | ||
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 3.12e-04 | 16 | 57 | 2 | 22780989 | |
| Pubmed | Identification and characterization of VPO1, a new animal heme-containing peroxidase. | 3.12e-04 | 16 | 57 | 2 | 18929642 | |
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 22627282 | ||
| Pubmed | 3.18e-04 | 198 | 57 | 4 | 24337577 | ||
| Pubmed | 3.43e-04 | 808 | 57 | 7 | 20412781 | ||
| Pubmed | 3.49e-04 | 83 | 57 | 3 | 28794006 | ||
| Pubmed | 3.53e-04 | 17 | 57 | 2 | 14695375 | ||
| Pubmed | 3.53e-04 | 17 | 57 | 2 | 28778798 | ||
| Interaction | GATA2 interactions | 1.12e-06 | 199 | 55 | 7 | int:GATA2 | |
| Interaction | SOX7 interactions | 2.92e-06 | 82 | 55 | 5 | int:SOX7 | |
| Interaction | IRF4 interactions | 3.49e-06 | 85 | 55 | 5 | int:IRF4 | |
| Interaction | GSC interactions | 3.92e-06 | 87 | 55 | 5 | int:GSC | |
| Interaction | LHX2 interactions | 1.03e-05 | 183 | 55 | 6 | int:LHX2 | |
| Interaction | GATA3 interactions | 1.17e-05 | 187 | 55 | 6 | int:GATA3 | |
| Interaction | ACTL6A interactions | 1.31e-05 | 289 | 55 | 7 | int:ACTL6A | |
| Interaction | ZNF503 interactions | 1.76e-05 | 57 | 55 | 4 | int:ZNF503 | |
| Interaction | PAX7 interactions | 2.21e-05 | 124 | 55 | 5 | int:PAX7 | |
| Interaction | PAX9 interactions | 2.78e-05 | 130 | 55 | 5 | int:PAX9 | |
| Interaction | SMARCA4 interactions | 3.40e-05 | 462 | 55 | 8 | int:SMARCA4 | |
| Interaction | GCM1 interactions | 3.55e-05 | 68 | 55 | 4 | int:GCM1 | |
| Interaction | SMARCA2 interactions | 4.14e-05 | 346 | 55 | 7 | int:SMARCA2 | |
| Interaction | SMARCC2 interactions | 4.70e-05 | 353 | 55 | 7 | int:SMARCC2 | |
| Interaction | ARID2 interactions | 6.05e-05 | 153 | 55 | 5 | int:ARID2 | |
| Interaction | DCAF7 interactions | 6.11e-05 | 368 | 55 | 7 | int:DCAF7 | |
| Interaction | CRX interactions | 6.53e-05 | 254 | 55 | 6 | int:CRX | |
| Interaction | FOXP1 interactions | 6.82e-05 | 256 | 55 | 6 | int:FOXP1 | |
| Interaction | ZBTB39 interactions | 9.90e-05 | 33 | 55 | 3 | int:ZBTB39 | |
| Interaction | EGR2 interactions | 1.02e-04 | 171 | 55 | 5 | int:EGR2 | |
| Interaction | ARID1A interactions | 1.03e-04 | 276 | 55 | 6 | int:ARID1A | |
| Interaction | TLX1 interactions | 1.14e-04 | 175 | 55 | 5 | int:TLX1 | |
| Interaction | SOX10 interactions | 1.16e-04 | 92 | 55 | 4 | int:SOX10 | |
| Interaction | FOXI1 interactions | 1.16e-04 | 92 | 55 | 4 | int:FOXI1 | |
| Interaction | PATL1 interactions | 1.20e-04 | 177 | 55 | 5 | int:PATL1 | |
| Interaction | SMARCE1 interactions | 1.28e-04 | 287 | 55 | 6 | int:SMARCE1 | |
| Interaction | TLX3 interactions | 1.38e-04 | 291 | 55 | 6 | int:TLX3 | |
| Interaction | HNF1B interactions | 1.68e-04 | 190 | 55 | 5 | int:HNF1B | |
| Interaction | TSG101 interactions | 1.72e-04 | 303 | 55 | 6 | int:TSG101 | |
| Interaction | TBL1XR1 interactions | 1.76e-04 | 192 | 55 | 5 | int:TBL1XR1 | |
| Interaction | JDP2 interactions | 2.05e-04 | 42 | 55 | 3 | int:JDP2 | |
| Interaction | FEV interactions | 2.28e-04 | 203 | 55 | 5 | int:FEV | |
| Interaction | PAX8 interactions | 2.39e-04 | 111 | 55 | 4 | int:PAX8 | |
| Interaction | TBR1 interactions | 2.56e-04 | 113 | 55 | 4 | int:TBR1 | |
| Interaction | NFIC interactions | 2.67e-04 | 210 | 55 | 5 | int:NFIC | |
| Interaction | NR3C1 interactions | ARID1B CEBPA SLC22A16 FBXO42 SVIL CHD7 CSMD2 EP300 ZNF687 KIF7 | 2.67e-04 | 974 | 55 | 10 | int:NR3C1 |
| Interaction | ZNF316 interactions | 2.69e-04 | 46 | 55 | 3 | int:ZNF316 | |
| Interaction | ZNF687 interactions | 2.74e-04 | 115 | 55 | 4 | int:ZNF687 | |
| Interaction | TBXT interactions | 2.83e-04 | 116 | 55 | 4 | int:TBXT | |
| Interaction | PLRG1 interactions | 3.04e-04 | 216 | 55 | 5 | int:PLRG1 | |
| Interaction | NANOG interactions | 3.18e-04 | 481 | 55 | 7 | int:NANOG | |
| Interaction | RTRAF interactions | 3.45e-04 | 222 | 55 | 5 | int:RTRAF | |
| Interaction | SMARCD1 interactions | 3.66e-04 | 349 | 55 | 6 | int:SMARCD1 | |
| Interaction | PTPN22 interactions | 3.87e-04 | 52 | 55 | 3 | int:PTPN22 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-06 | 187 | 57 | 5 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.13e-06 | 187 | 57 | 5 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.32e-06 | 197 | 57 | 5 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Control-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.32e-06 | 197 | 57 | 5 | 925bf0d38e4ce279fa45f455546ebd199282c0df | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-05 | 139 | 57 | 4 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.25e-05 | 160 | 57 | 4 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.25e-05 | 160 | 57 | 4 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.06e-05 | 166 | 57 | 4 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.80e-05 | 171 | 57 | 4 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 173 | 57 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 173 | 57 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 180 | 57 | 4 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 180 | 57 | 4 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 181 | 57 | 4 | 75340f0c06977c88f9d2e56265f4aa84d706d2c6 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 183 | 57 | 4 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.03e-05 | 184 | 57 | 4 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.22e-05 | 185 | 57 | 4 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 9.41e-05 | 186 | 57 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.41e-05 | 186 | 57 | 4 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | 1fd763c4e9904e866586a506ee7b0b285170481d | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.00e-04 | 189 | 57 | 4 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.04e-04 | 191 | 57 | 4 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.06e-04 | 192 | 57 | 4 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Endothelial-A|World / shred on cell class and cell subclass (v4) | 1.06e-04 | 192 | 57 | 4 | 9919cdc0ce833894525dba429f251ea1b094fbd8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 192 | 57 | 4 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 194 | 57 | 4 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 194 | 57 | 4 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.15e-04 | 196 | 57 | 4 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.15e-04 | 196 | 57 | 4 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 197 | 57 | 4 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 197 | 57 | 4 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-04 | 197 | 57 | 4 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | distal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-04 | 198 | 57 | 4 | dc93886439a378a0c71e99acb8081bfb6b6d467b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-04 | 198 | 57 | 4 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | moderate-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-04 | 198 | 57 | 4 | 7ecce5e266bb08797088cc8f8309e0c7b48df5c9 | |
| ToppCell | COVID-19-Epithelial-AT2,_AT1_cells|COVID-19 / Condition, Lineage and Cell class | 1.20e-04 | 198 | 57 | 4 | 7e6f089e71e70190ff8486341ab06719d7741467 | |
| ToppCell | distal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-04 | 198 | 57 | 4 | 9d1d95e7703cfc70a8ad427e400c340dbd205db8 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.20e-04 | 198 | 57 | 4 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.20e-04 | 198 | 57 | 4 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.20e-04 | 198 | 57 | 4 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.20e-04 | 198 | 57 | 4 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | distal-mesenchymal-Fibromyocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.20e-04 | 198 | 57 | 4 | fbfac1d10e4224990a094cc84b74bbc206881423 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-04 | 199 | 57 | 4 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 199 | 57 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 199 | 57 | 4 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid-Megakaryocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | 6e7f7214317f2af2ba8523df9896f54b7294d58a | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Myeloid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | 5f499595597c10857bba8272f62afe4d32d733ac | |
| ToppCell | Biopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.24e-04 | 200 | 57 | 4 | 2aaf130d702d18c277d16b6800f006a53ed653fb | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-04 | 200 | 57 | 4 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.65e-04 | 83 | 57 | 3 | 7893ce9fbf34c6250dca9c265fe9b2d4cb889ade | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.87e-04 | 120 | 57 | 3 | 2b7596946f9268c4202348adf3069decd8313bb0 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.24e-04 | 123 | 57 | 3 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 5.36e-04 | 124 | 57 | 3 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.36e-04 | 124 | 57 | 3 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.62e-04 | 126 | 57 | 3 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.62e-04 | 126 | 57 | 3 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Mup5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.75e-04 | 127 | 57 | 3 | 6df92f80b8922ca00eb383f79cd8dda4d602adfc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.75e-04 | 127 | 57 | 3 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-04 | 128 | 57 | 3 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.29e-04 | 131 | 57 | 3 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.29e-04 | 131 | 57 | 3 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.63e-04 | 140 | 57 | 3 | 276b3fa924176426efb31112ed4d355407f0b218 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.63e-04 | 140 | 57 | 3 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.79e-04 | 141 | 57 | 3 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.45e-04 | 145 | 57 | 3 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.45e-04 | 145 | 57 | 3 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 8.61e-04 | 146 | 57 | 3 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.79e-04 | 147 | 57 | 3 | aba44c7057096483c4293a7ebcf8ccc8baed0231 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.96e-04 | 148 | 57 | 3 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.14e-04 | 149 | 57 | 3 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.49e-04 | 151 | 57 | 3 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | P03-Epithelial-epithelial_progenitor_cell-epi_progenitor|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.49e-04 | 151 | 57 | 3 | fce04bce66411c21cd5d4d41375f26f1f50f3348 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.68e-04 | 152 | 57 | 3 | 655d47efe0608d729801f1f01668e84c1bc0675f | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.68e-04 | 152 | 57 | 3 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-03 | 155 | 57 | 3 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 155 | 57 | 3 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-03 | 155 | 57 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 155 | 57 | 3 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-03 | 156 | 57 | 3 | 17c38d3b03fc38cb125cf0d165b2fd694cd88edd | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 157 | 57 | 3 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 157 | 57 | 3 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 1.06e-03 | 157 | 57 | 3 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.08e-03 | 158 | 57 | 3 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.10e-03 | 159 | 57 | 3 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.10e-03 | 159 | 57 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-03 | 159 | 57 | 3 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epi_progenitor|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-03 | 159 | 57 | 3 | a4bfd59c53237964fc24a24de5c1925fdd01db99 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-03 | 162 | 57 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-03 | 163 | 57 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-03 | 163 | 57 | 3 | 03b2ec226adffba3ce893f3d12e549c841e662fd | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-03 | 164 | 57 | 3 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-03 | 164 | 57 | 3 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.20e-03 | 164 | 57 | 3 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | lymphoid-B_cell-pro-B|lymphoid / Lineage, cell class and subclass | 1.23e-03 | 165 | 57 | 3 | 8126c2f7810fc6e09b18783aadf6434ae12b0514 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-03 | 166 | 57 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-03 | 166 | 57 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-03 | 166 | 57 | 3 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.25e-03 | 166 | 57 | 3 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.25e-03 | 166 | 57 | 3 | a853005a5587d42daecdf2e23a93109919021a4f | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.19e-06 | 55 | 54 | 4 | C0079744 | |
| Disease | Leukemia, Myelocytic, Acute | 1.64e-05 | 173 | 54 | 5 | C0023467 | |
| Disease | Inherited acute myeloid leukemia | 1.97e-05 | 4 | 54 | 2 | C4707228 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.88e-05 | 41 | 54 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.88e-05 | 41 | 54 | 3 | C0858252 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 6.86e-05 | 7 | 54 | 2 | C2745997 | |
| Disease | neuroblastoma (is_marker_for) | 9.14e-05 | 8 | 54 | 2 | DOID:769 (is_marker_for) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 9.82e-05 | 801 | 54 | 8 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | neutrophil percentage of leukocytes | 1.19e-04 | 610 | 54 | 7 | EFO_0007990 | |
| Disease | neutrophil-to-lymphocyte ratio | 3.70e-04 | 185 | 54 | 4 | EFO_0008447 | |
| Disease | Acute myeloid leukemia | 4.39e-04 | 17 | 54 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 4.39e-04 | 17 | 54 | 2 | 601626 | |
| Disease | ischemia (implicated_via_orthology) | 4.39e-04 | 17 | 54 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.52e-04 | 195 | 54 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | hematocrit | 4.75e-04 | 1011 | 54 | 8 | EFO_0004348 | |
| Disease | Neurodevelopmental Disorders | 6.69e-04 | 93 | 54 | 3 | C1535926 | |
| Disease | tooth agenesis | 7.42e-04 | 22 | 54 | 2 | EFO_0005410 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 8.84e-04 | 24 | 54 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | Kallmann Syndrome | 1.04e-03 | 26 | 54 | 2 | C0162809 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.24e-03 | 115 | 54 | 3 | EFO_0007878, EFO_0010724 | |
| Disease | Crohn's disease | 1.26e-03 | 441 | 54 | 5 | EFO_0000384 | |
| Disease | lymphocyte percentage of leukocytes | 1.32e-03 | 665 | 54 | 6 | EFO_0007993 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.37e-03 | 670 | 54 | 6 | EFO_0006335, EFO_0006336 | |
| Disease | Familial aplasia of the vermis | 1.38e-03 | 30 | 54 | 2 | C0431399 | |
| Disease | Squamous cell carcinoma | 1.54e-03 | 124 | 54 | 3 | C0007137 | |
| Disease | myeloid white cell count | 1.54e-03 | 937 | 54 | 7 | EFO_0007988 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.57e-03 | 125 | 54 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.57e-03 | 125 | 54 | 3 | C1879321 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.67e-03 | 33 | 54 | 2 | DOID:4467 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPSMPGSAQCHHRPD | 31 | A8MWP4 | |
| PIMPPGSQGSHIHCP | 806 | Q09472 | |
| GRGPASHMQHPGQLP | 906 | Q9P281 | |
| LVSCGHPGSPPHSQM | 2771 | Q7Z408 | |
| HPHGSVAGFMGVPAP | 276 | O95076 | |
| NPHCGGSVTMPPINL | 421 | Q8IVW4 | |
| HPLGGVHPMELGPTA | 756 | Q9BZ11 | |
| PTIHPMSFSPAGCHP | 146 | B6SEH9 | |
| PHPSPGGQMHAGISS | 886 | Q8NFD5 | |
| GPGHLSHVPQQSPSM | 231 | Q9P2D1 | |
| CGHVPVSPKAPSMLG | 871 | Q99650 | |
| NCIVTTHGPPPMAGH | 221 | Q6P3S6 | |
| THGPPPMAGHSSCVI | 226 | Q6P3S6 | |
| GQRGPGTHMSEPPHN | 2451 | Q04721 | |
| GPLAHMPNASCGVPT | 181 | P04629 | |
| CRGSVPALMPPDHHV | 316 | Q8NG48 | |
| VTVMRGHCHPPDLGG | 471 | Q4VC44 | |
| VPQAHVQSGMVPSHP | 1246 | Q99700 | |
| PTIHPMSFSPAGCHP | 146 | B6SEH8 | |
| GPSHPCLAGLLGPMH | 51 | B1ANH7 | |
| SPGRSPMQAVHPVHV | 621 | Q9H334 | |
| AHAHVLGMVPPACLP | 571 | Q2M1P5 | |
| PHIEMIPGAHSIPSG | 531 | Q86TG7 | |
| MAGHRPSNHFCPLPG | 1 | Q8N7G0 | |
| PFTTIHMGVPHSGPT | 1191 | Q5T7B8 | |
| PHDSARGGMIPHPQS | 156 | P08151 | |
| VAVGQCPLVGPGPMH | 556 | Q09013 | |
| LCSMHHLVPGGSAPP | 1226 | Q86UR5 | |
| HLPSVCGGRFHPQPM | 666 | E5RHQ5 | |
| GGQMCRPHLLHSPGL | 81 | P23769 | |
| PGLATMGTQPATHHP | 231 | P23769 | |
| TIAFSPQMGHLHPGC | 3691 | Q4G0P3 | |
| TGGSIVIHSPMGQPH | 381 | Q6AI39 | |
| GHVQSPPSCTSPHQM | 201 | Q14241 | |
| AHCGQTTMHLQPGHP | 211 | P49715 | |
| ASNHPIMKTGEPHCP | 296 | O75976 | |
| CPSSVGGHPPQMRVV | 1651 | Q9BZC7 | |
| HFCPHPMSLSLSQPG | 616 | P37088 | |
| PAPRDMACQVQPHHG | 1191 | Q8TDX9 | |
| LDFGMSPPACAGPHH | 376 | Q6UY18 | |
| CGSYLTPMHHQLPGP | 201 | P32243 | |
| VNMPSGPHCLCPQHL | 111 | P00748 | |
| MCIPPPNVTGSLHIG | 141 | Q5ST30 | |
| PIPASCSGGTHPVMA | 751 | O95425 | |
| MGEHPSPGPAVAACA | 1 | P58872 | |
| SVFMGVTPHHVCRPP | 41 | Q86VW1 | |
| HADIGGITPGSMPPH | 856 | O14841 | |
| PCMPATILGPVHLAG | 1271 | Q9P2F8 | |
| QSPGGMPHLPGDVLH | 311 | Q8NDZ2 | |
| DMQPGHHETSTPAGP | 156 | P18827 | |
| MGPGQPASTCVHLAP | 1 | Q2KHM9 | |
| SQGHSSPVMHPGSPG | 486 | P61129 | |
| SPVMHPGSPGHHPCA | 491 | P61129 | |
| HMVAPAHPGLPTSGI | 291 | Q9HCS4 | |
| MNPIDSCARHHGPPI | 286 | Q6ZQQ2 | |
| YHTIHPSLPMENGPG | 426 | Q9H5I5 | |
| MPCGFSPSPVAHHLV | 1 | Q9P283 | |
| CHMHIPTSGAPGSPG | 571 | Q96F45 | |
| MHKNRPPHVCPECGG | 726 | Q8N1G0 | |
| HVLMESTGPAGHCPH | 516 | Q9C0I4 | |
| PNAAGQLPTSPGHMH | 851 | O94979 |